Biofrontera Inc.
BFRI
Rank in Stocks
#31612
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Share Price
$0.8066
Last synced: 2026-10-20
Market Cap
$11.98M
Change (1 day)
0.11%
Change (1 year)
-72.66%
Country
US
Trade Biofrontera Inc. (BFRI)
Category
Healthcare
Stock price history for Biofrontera Inc. (BFRI)
Highest end of day price: $2.93 on 2024-06-01
Lowest end of day price: $328.16 on 2006-10-01
Lowest end of day price: $328.16 on 2006-10-01
Stock price history of Biofrontera Inc. from 2006 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2024 | -73.04% |
| 2023 | -68.52% |
| 2022 | -5.85% |
| 2021 | -48.56% |
| 2020 | -30.24% |
| 2019 | -15.14% |
| 2018 | 34.15% |
| 2017 | 41.58% |
| 2016 | 70.60% |
| 2015 | -31.22% |
| 2014 | -36.74% |
| 2013 | -4.76% |
| 2012 | 28.04% |
| 2011 | 56.02% |
| 2010 | -25.62% |
| 2009 | 48.88% |
| 2008 | -87.41% |
| 2007 | -3.58% |
| 2006 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $62.21 | 65.98% |
US
|
|
| $49.82 | 48.82% |
SE
|
|
| $179.82 | 37.07% |
FR
|
|
| $62.81 | 5.96% |
IT
|
|
| $116.87 | 55.01% |
US
|
